Maria Ines Mitrani is Chief Science Officer of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 102 Million shares of OCEL, which is worth approximately $117 Million. The most recent transaction as insider was on Oct 29, 2021, when has been sold 15,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102M
0% 3M change
0% 12M change
Total Value Held $117 Million

MARIA INES MITRANI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 29 2021
SELL
Other acquisition or disposition
-
15,000,000 Reduced 12.85%
101,707,890 Common Stock
Oct 29 2021
BUY
Other acquisition or disposition
-
15,000,000 Added 11.39%
116,707,890 Common Stock
Jun 17 2021
SELL
Open market or private sale
$7,000 $0.14 p/Share
50,000 Reduced 0.04%
116,707,890 Common Stock
Jun 16 2021
SELL
Open market or private sale
$8,000 $0.16 p/Share
50,000 Reduced 0.04%
116,757,890 Common Stock
Jun 15 2021
SELL
Open market or private sale
$8,000 $0.16 p/Share
50,000 Reduced 0.04%
116,807,890 Common Stock
Jun 14 2021
SELL
Open market or private sale
$7,000 $0.14 p/Share
50,000 Reduced 0.04%
116,857,890 Common Stock
Jun 11 2021
SELL
Open market or private sale
$6,987 $0.14 p/Share
49,910 Reduced 0.04%
116,907,890 Common Stock
Jun 10 2021
SELL
Open market or private sale
$11,928 $0.14 p/Share
85,200 Reduced 0.07%
116,957,800 Common Stock
Jun 09 2021
SELL
Open market or private sale
$12,000 $0.15 p/Share
80,000 Reduced 0.07%
117,043,000 Common Stock
Jun 08 2021
SELL
Open market or private sale
$13,000 $0.13 p/Share
100,000 Reduced 0.09%
117,123,000 Common Stock
Jun 07 2021
SELL
Open market or private sale
$12,000 $0.12 p/Share
100,000 Reduced 0.09%
117,223,000 Common Stock
Jun 04 2021
SELL
Open market or private sale
$14,000 $0.14 p/Share
100,000 Reduced 0.09%
117,323,000 Common Stock
Jun 02 2021
SELL
Open market or private sale
$14,400 $0.16 p/Share
90,000 Reduced 0.08%
117,423,000 Common Stock
Jun 01 2021
SELL
Open market or private sale
$9,500 $0.19 p/Share
50,000 Reduced 0.04%
117,513,000 Common Stock
May 28 2021
SELL
Open market or private sale
$9,000 $0.18 p/Share
50,000 Reduced 0.04%
117,563,000 Common Stock
May 27 2021
SELL
Open market or private sale
$18,000 $0.18 p/Share
100,000 Reduced 0.08%
117,613,000 Common Stock
May 26 2021
SELL
Open market or private sale
$7,600 $0.19 p/Share
40,000 Reduced 0.03%
117,713,000 Common Stock
May 25 2021
SELL
Open market or private sale
$20,000 $0.2 p/Share
100,000 Reduced 0.08%
117,753,000 Common Stock
May 24 2021
SELL
Open market or private sale
$9,000 $0.18 p/Share
50,000 Reduced 0.04%
117,853,000 Common Stock
May 21 2021
SELL
Open market or private sale
$9,000 $0.18 p/Share
50,000 Reduced 0.04%
117,903,000 Common Stock
May 20 2021
SELL
Open market or private sale
$19,000 $0.19 p/Share
100,000 Reduced 0.08%
117,953,000 Common Stock
May 19 2021
SELL
Open market or private sale
$23,460 $0.23 p/Share
102,000 Reduced 0.09%
118,053,000 Common Stock
May 18 2021
SELL
Open market or private sale
$11,000 $0.22 p/Share
50,000 Reduced 0.04%
118,155,000 Common Stock
May 17 2021
SELL
Open market or private sale
$15,750 $0.21 p/Share
75,000 Reduced 0.06%
118,205,000 Common Stock
May 14 2021
SELL
Open market or private sale
$12,000 $0.24 p/Share
50,000 Reduced 0.04%
118,280,000 Common Stock
MIM

Maria Ines Mitrani

Chief Science Officer
Miami, FL

Track Institutional and Insider Activities on OCEL

Follow Organicell Regenerative Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL